ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OMCL Omnicell Inc

29.29
2.12 (7.80%)
After Hours
Last Updated: 21:03:51
Delayed by 15 minutes
Share Name Share Symbol Market Type
Omnicell Inc NASDAQ:OMCL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.12 7.80% 29.29 28.72 29.82 29.64 26.89 27.17 604,892 21:03:51

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Omnicell, Inc. of Pendency of Class Action Lawsuit and a Lea...

06/04/2015 4:02pm

GlobeNewswire Inc.


Omnicell (NASDAQ:OMCL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Omnicell Charts.

The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired common shares of Omnicell, Inc. (Nasdaq:OMCL) between May 2, 2014 and March 2, 2015.         

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. If you purchased or otherwise acquired Omnicell, Inc. ("Omnicell") securities between May 2, 2014, and March 2, 2015, your rights may be affected by this action. To get more information, go to:

HTTP://ZLK.9NL.COM/OMNICELL-INFOSHEET

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that the Company misrepresented and/or failed to disclose: (a) the existence of a "side letter" arrangement with a Company customer for certain discounts and Company products that were provided at no cost, but which were not reflected in final invoices paid by the customer; (b) the Company lacked adequate internal controls over financial reporting; and (c) that as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

If you suffered a loss in Accelerate Diagnostics you have until May 18, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (866) 367-6510
         www.zlk.com

1 Year Omnicell Chart

1 Year Omnicell Chart

1 Month Omnicell Chart

1 Month Omnicell Chart

Your Recent History

Delayed Upgrade Clock